This site is intended for health professionals only


Prescribing information to support QIPP document



GPs are set to be enrolled in schemes to switch patients en masse to atorvastatin in the wake of an analysis for the Government’s QIPP programme finding its price could plummet by as much as 95% when it comes off patent later this year.

Read the ‘Prescribing information to support QIPP’ document here